-+ 0.00%
-+ 0.00%
-+ 0.00%

This Oracle Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday

Benzinga·02/25/2026 14:41:02
Listen to the news

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • Mizuho analyst Yaron Kinar upgraded Neptune Insurance Holdings Inc (NYSE:NP) from Underperform to Neutral and lowered the price target from $26 to $24. Neptune Insurance shares closed at $20.40 on Tuesday. See how other analysts view this stock.
  • Citizens analyst Reni J. Benjamin upgraded Iovance Biotherapeutics Inc (NASDAQ:IOVA) from Market Perform to Market Outperform and announced a $5 price target. Iovance Biotherapeutics shares closed at $3.78 on Tuesday. See how other analysts view this stock.
  • Oppenheimer analyst Brian Schwartz upgraded Oracle Corp (NYSE:ORCL) from Perform to Outperform and announced a $185 price target. Oracle shares closed at $146.14 on Tuesday. See how other analysts view this stock.
  • Jefferies analyst Julien Dumoulin-Smith upgraded Enphase Energy Inc (NASDAQ:ENPH) from Hold to Buy and raised the price target from $42 to $57. Enphase Energy shares closed at $49.74 on Tuesday. See how other analysts view this stock.
  • UBS analyst David Vogt upgraded IBM (NYSE:IBM) from Sell to Neutral and maintained the price target of $236. IBM shares closed at $229.42 on Tuesday. See how other analysts view this stock.

Considering buying ORCL stock? Here’s what analysts think:

Photo via Shutterstock